Literature DB >> 25201273

Screening the life cycle of Schistosoma mansoni using high-resolution mass spectrometry.

Mônica Siqueira Ferreira1, Diogo Noin de Oliveira1, Rosimeire Nunes de Oliveira2, Silmara Marques Allegretti2, Rodrigo Ramos Catharino3.   

Abstract

Schistosomiasis is a common tropical disease caused by Schistosoma species Schistosomiasis' pathogenesis is known to vary according to the worms' strain. Moreover, high parasitical virulence is directly related to eggs release and granulomatous inflammation in the host's organs. This virulence might be influenced by different classes of molecules, such as lipids. Therefore, better understanding of the metabolic profile of these organisms is necessary, especially for an increased potential of unraveling strain virulence mechanisms and resistance to existing treatments. In this report, direct-infusion electrospray high-resolution mass spectrometry (ESI(+)-HRMS) along with the lipidomic platform were employed to rapidly characterize and differentiate two Brazilian S. mansoni strains (BH and SE) in three stages of their life cycle: eggs, miracidia and cercariae, with samples from experimental animals (Swiss/SPF mice). Furthermore, urine samples of the infected and uninfected mice were analyzed to assess the possibility of direct diagnosis. All samples were differentiated using multivariate data analysis, PCA, which helped electing markers from distinct lipid classes; phospholipids, diacylglycerols and triacylglycerols, for example, clearly presented different intensities in some stages and strains, as well as in urine samples. This indicates that biochemical characterization of S. mansoni may help narrowing-down the investigation of new therapeutic targets according to strain composition and aggressiveness of disease. Interestingly, lipid profile of infected mice urine varies when compared to control samples, indicating that direct diagnosis of schistosomiasis from urine may be feasible.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HR-FTMS; Life cycle; Lipid profile; Schistosomamansoni

Mesh:

Year:  2014        PMID: 25201273     DOI: 10.1016/j.aca.2014.06.013

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  7 in total

Review 1.  The metabolic control of schistosome egg production.

Authors:  Edward J Pearce; Stanley Ching-Cheng Huang
Journal:  Cell Microbiol       Date:  2015-04-30       Impact factor: 3.715

Review 2.  Novel advances in shotgun lipidomics for biology and medicine.

Authors:  Miao Wang; Chunyan Wang; Rowland H Han; Xianlin Han
Journal:  Prog Lipid Res       Date:  2015-12-15       Impact factor: 16.195

Review 3.  Shotgun lipidomics in substantiating lipid peroxidation in redox biology: Methods and applications.

Authors:  Changfeng Hu; Miao Wang; Xianlin Han
Journal:  Redox Biol       Date:  2017-04-24       Impact factor: 11.799

4.  Development of a High Coverage Pseudotargeted Lipidomics Method Based on Ultra-High Performance Liquid Chromatography-Mass Spectrometry.

Authors:  Qiuhui Xuan; Chunxiu Hu; Di Yu; Lichao Wang; Yang Zhou; Xinjie Zhao; Qi Li; Xiaoli Hou; Guowang Xu
Journal:  Anal Chem       Date:  2018-06-08       Impact factor: 6.986

Review 5.  Helminth lipidomics: Technical aspects and future prospects.

Authors:  Tao Wang; Shuai Nie; Gavin E Reid; Robin B Gasser
Journal:  Curr Res Parasitol Vector Borne Dis       Date:  2021-02-24

6.  The anti-fecundity effect of 5-azacytidine (5-AzaC) on Schistosoma mansoni is linked to dis-regulated transcription, translation and stem cell activities.

Authors:  Kathrin K Geyer; Sabrina E Munshi; Martin Vickers; Michael Squance; Toby J Wilkinson; Daniel Berrar; Cristian Chaparro; Martin T Swain; Karl F Hoffmann
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-04-01       Impact factor: 4.077

Review 7.  The foundations and development of lipidomics.

Authors:  Xianlin Han; Richard W Gross
Journal:  J Lipid Res       Date:  2021-12-22       Impact factor: 5.922

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.